SALT LAKE CITY, July 31, 2023 /PRNewswire/ — Sera Prognostics Inc., The Pregnancy Company (NASDAQ: SERA), focused on improving maternal and neonatal health by providing innovative pregnancy biomarker information to doctors and patients, today announced that it will report second quarter fiscal year 2023 financial results on Wednesday, August 9,…Read More
Sera Prognostics Announces Conference Call and Webcast of Second Quarter Fiscal Year 2023 Financial Results on August 9 2023
